Current Ratio

With a current ratio of 3.21x, Bio-Rad holds $3.21 in current assets (like cash and receivables) for every $1 of short-term liabilities, indicating strong liquidity to cover near-term obligations.

This is well above the healthcare sector median of 2.02x, placing the company in the 69th percentile among peers—meaning it has higher liquidity than about two-thirds of comparable firms. However, the metric has been decreasing over the last eight quarters; the year-over-year and quarter-over-quarter changes are listed as not available, so the direction is clear but the pace cannot be measured precisely from the provided data. The combination of a high current ratio with a declining trend suggests that while liquidity remains ample, the erosion over time could signal a narrowing safety margin or changing working capital management. For investors, this presents a mixed picture: the absolute level supports financial stability, but the downward trend warrants monitoring to ensure it doesn't slip toward the sector median. This mixed dynamic aligns with the overall NEUTRAL verdict—it does not strongly contradict the view, as liquidity is a positive factor offset by the negative trajectory.

Frequently Asked Questions

Closest Sector Peers